Literature DB >> 26690307

Probing Protein Surfaces: QSAR Analysis with Helix Mimetics.

Valeria Azzarito1,2, Philip Rowell2,3, Anna Barnard4,5, Thomas A Edwards2,3, Andrew Macdonald2,3, Stuart L Warriner6,7, Andrew J Wilson8,9.   

Abstract

α-Helix-mediated protein-protein interactions (PPIs) are important targets for small-molecule inhibition; however, generic approaches to inhibitor design are in their infancy and would benefit from QSAR analyses to rationalise the noncovalent basis of molecular recognition by designed ligands. Using a helix mimetic based on an oligoamide scaffold, we have exploited the power of a modular synthesis to access compounds that can readily be used to understand the noncovalent determinants of hDM2 recognition by this series of cell-active p53/hDM2 inhibitors.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  chemical biology; foldamers; helix mimetics; p53/hDM2; protein-protein interactions

Mesh:

Substances:

Year:  2016        PMID: 26690307      PMCID: PMC6591138          DOI: 10.1002/cbic.201500504

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  38 in total

1.  Discovery of potent antagonists of the interaction between human double minute 2 and tumor suppressor p53.

Authors:  C García-Echeverría; P Chène; M J Blommers; P Furet
Journal:  J Med Chem       Date:  2000-08-24       Impact factor: 7.446

2.  Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox.

Authors:  Christopher A Hunter
Journal:  Angew Chem Int Ed Engl       Date:  2004-10-11       Impact factor: 15.336

Review 3.  Synthetic non-peptide mimetics of alpha-helices.

Authors:  Jessica M Davis; Lun K Tsou; Andrew D Hamilton
Journal:  Chem Soc Rev       Date:  2007-01-04       Impact factor: 54.564

Review 4.  BCL-2 family antagonists for cancer therapy.

Authors:  Guillaume Lessene; Peter E Czabotar; Peter M Colman
Journal:  Nat Rev Drug Discov       Date:  2008-12       Impact factor: 84.694

5.  Synthetic inhibitors of extended helix-protein interactions based on a biphenyl 4,4'-dicarboxamide scaffold.

Authors:  Johanna M Rodriguez; Laura Nevola; Nathan T Ross; Gui-in Lee; Andrew D Hamilton
Journal:  Chembiochem       Date:  2009-03-23       Impact factor: 3.164

6.  Cell-permeable beta-peptide inhibitors of p53/hDM2 complexation.

Authors:  Elizabeth A Harker; Alanna Schepartz
Journal:  Chembiochem       Date:  2009-04-17       Impact factor: 3.164

Review 7.  Targeting protein-protein interactions for therapeutic intervention: a challenge for the future.

Authors:  Giovanna Zinzalla; David E Thurston
Journal:  Future Med Chem       Date:  2009-04       Impact factor: 3.808

8.  Synthetic alpha-helix mimetics as agonists and antagonists of islet amyloid polypeptide aggregation.

Authors:  Ishu Saraogi; James A Hebda; Jorge Becerril; Lara A Estroff; Andrew D Miranker; Andrew D Hamilton
Journal:  Angew Chem Int Ed Engl       Date:  2010       Impact factor: 15.336

9.  Structure-activity studies in a family of beta-hairpin protein epitope mimetic inhibitors of the p53-HDM2 protein-protein interaction.

Authors:  Rudi Fasan; Ricardo L A Dias; Kerstin Moehle; Oliver Zerbe; Daniel Obrecht; Peer R E Mittl; Markus G Grütter; John A Robinson
Journal:  Chembiochem       Date:  2006-03       Impact factor: 3.164

10.  Structure and function of benzoylurea-derived alpha-helix mimetics targeting the Bcl-x(L)/Bak binding interface.

Authors:  Johanna M Rodriguez; Nathan T Ross; William P Katt; Deepali Dhar; Gui-In Lee; Andrew D Hamilton
Journal:  ChemMedChem       Date:  2009-04       Impact factor: 3.466

View more
  1 in total

1.  Query-guided protein-protein interaction inhibitor discovery.

Authors:  Sergio Celis; Fruzsina Hobor; Thomas James; Gail J Bartlett; Amaurys A Ibarra; Deborah K Shoemark; Zsófia Hegedüs; Kristina Hetherington; Derek N Woolfson; Richard B Sessions; Thomas A Edwards; David M Andrews; Adam Nelson; Andrew J Wilson
Journal:  Chem Sci       Date:  2021-03-02       Impact factor: 9.825

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.